DEXTRAN SULPHATE, A POTENT ANTI-HIV AGENT IN VITRO HAVING SYNERGISM WITH ZIDOVUDINE

The Lancet

Volumn 329, Issue 8546, 1987, Pages 1379-

  Ueno, Ryuji ^a   Kuno, Sachiko ^a  

^a Department of Medicine Research Institute Ueno Fine Chemicals Industry Ltd ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; ZIDOVUDINE;

BLOOD AND HEMOPOIETIC SYSTEM; CELL CULTURE; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIVIRAL AGENTS; DEXTRAN SULFATE; DEXTRANS; DRUG SYNERGISM; HIV; HUMAN; THYMIDINE; ZIDOVUDINE;

EID: 0023274352     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)90681-7     Document Type: Article

References (3)

1. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay
2. 3'-azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphoadenopathy-associated virus in vitro
3. 2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus m vitro